| 228 |
10.1001/jamaoncol.2020.4564 |
Efficacy And Safety Of Nivolumab Plus Ipilimumab In
Patients With Advanced Hepatocellular Carcinoma Previously Treated With
Sorafenib |
Yau, Thomas; Kang, Yoon-Koo; Kim, Tae-You; El-Khoueiry,
Anthony B.; Santoro, Armando; Sangro, Bruno; Melero, Ignacio; Kudo,
Masatoshi; Hou, Ming-Mo; Matilla, Ana; Tovoli, Francesco; Knox, Jennifer
J.; Ruth He, Aiwu; El-Rayes, Bassel F.; Acosta-Rivera, Mirelis; Lim,
Ho-Yeong; Neely, Jaclyn; Shen, Yun; Wisniewski, Tami; Anderson, Jeffrey;
Hsu, Chiun |
Jama Oncology |
2020 |
| 7465 |
10.1016/j.jhep.2018.04.010 |
Outcomes Of Sequential Treatment With Sorafenib
Followed By Regorafenib For Hcc: Additional Analyses From The Phase Iii
Resorce Trial |
Finn, Richard S.; Merle, Philippe; Granito, Alessandro;
Huang, Yi-Hsiang; Bodoky, Gyorgy; Pracht, Marc; Yokosuka, Osamu;
Rosmorduc, Olivier; Gerolami, Rene; Caparello, Chiara; Cabrera, Roniel;
Chang, Charissa; Sun, Weijing; Leberre, Marie-Aude; Baumhauer, Annette;
Meinhardt, Gerold; Bruix, Jordi |
Journal Of Hepatology |
2018 |
| 7475 |
10.1016/j.jhep.2019.05.014 |
Nivolumab In Advanced Hepatocellular Carcinoma:
Sorafenib-Experienced Asian Cohort Analysis |
Yau, Thomas; Hsu, Chiun, 0000-0002-1122-0055; Kim,
Tae-You; Choo, Su-Pin; Kang, Yoon-Koo; Hou, Ming-Mo; Numata, Kazushi;
Yeo, Winnie; Chopra, Akhil; Ikeda, Masafumi; Kuromatsu, Ryoko;
Moriguchi, Michihisa; Chao, Yee; Zhao, Huanyu; Anderson, Jeffrey; Cruz,
Christine Dela; Kudo, Masatoshi, 0000-0002-4102-3474 |
Journal Of Hepatology |
2019 |
| 7479 |
10.1016/j.jhep.2019.08.006 |
Impact Of Combined Selective Internal Radiation Therapy
And Sorafenib On Survival In Advanced Hepatocellular Carcinoma |
Ricke, Jens; Klumpen, Heinz Josef; Amthauer, Holger;
Bargellini, Irene; Bartenstein, Peter; De Toni, Enrico N.; Gasbarrini,
Antonio; Pech, Maciej; Peck-Radosavljevic, Markus, 0000-0002-0597-2728;
Popovi<U+010D>, Peter; Rosmorduc, Olivier; Schott, Eckart;
Seidensticker, Max; Verslype, Chris; Sangro, Bruno; Malfertheiner,
Peter |
Journal Of Hepatology |
2019 |
| 7498 |
10.1016/j.jhep.2020.07.026 |
Association Of Inflammatory Biomarkers With Clinical
Outcomes In Nivolumab-Treated Patients With Advanced Hepatocellular
Carcinoma |
Sangro, Bruno; Melero, Ignacio; Wadhawan, Samir; Finn,
Richard S., 0000-0003-2494-2126; Abou-Alfa, Ghassan K.; Cheng, Ann-Lii;
Yau, Thomas; Furuse, Junji, 0000-0003-0663-6117; Park, Joong-Won,
0000-0001-9972-0494; Boyd, Zachary; Tang, Hao (Tracy); Shen, Yun,
0000-0002-2078-1161; Tschaika, Marina; Neely, Jaclyn; El-Khoueiry,
Anthony |
Journal Of Hepatology |
2020 |
| 10079 |
10.1016/s0140-6736(18)30207-1 |
Lenvatinib Versus Sorafenib In First-Line Treatment Of
Patients With Unresectable Hepatocellular Carcinoma: A Randomised Phase
3 Non-Inferiority Trial |
Kudo, Masatoshi; Finn, Richard S; Qin, Shukui; Han,
Kwang-Hyub; Ikeda, Kenji; Piscaglia, Fabio; Baron, Ari; Park, Joong-Won;
Han, Guohong; Jassem, Jacek; Blanc, Jean Frederic; Vogel, Arndt; Komov,
Dmitry; Evans, T R Jeffry; Lopez, Carlos; Dutcus, Corina; Guo, Matthew;
Saito, Kenichi; Kraljevic, Silvija; Tamai, Toshiyuki; Ren, Min; Cheng,
Ann-Lii |
The Lancet |
2018 |
| 10251 |
10.1016/s1470-2045(18)30146-3 |
Tivantinib For Second-Line Treatment Of Met-High,
Advanced Hepatocellular Carcinoma (Metiv-Hcc): A Final Analysis Of A
Phase 3, Randomised, Placebo-Controlled Study |
Rimassa, Lorenza; Assenat, Eric; Peck-Radosavljevic,
Markus; Pracht, Marc; Zagonel, Vittorina; Mathurin, Philippe; Rota
Caremoli, Elena; Porta, Camillo; Daniele, Bruno; Bolondi, Luigi;
Mazzaferro, Vincenzo; Harris, William; Damjanov, Nevena; Pastorelli,
Davide; Reig, Maria; Knox, Jennifer; Negri, Francesca; Trojan, Jorg;
Lopez Lopez, Carlos; Personeni, Nicola; Decaens, Thomas; Dupuy, Marie;
Sieghart, Wolfgang; Abbadessa, Giovanni; Schwartz, Brian; Lamar, Maria;
Goldberg, Terri; Shuster, Dale; Santoro, Armando; Bruix, Jordi |
The Lancet Oncology |
2018 |
| 10255 |
10.1016/s1470-2045(18)30351-6 |
Pembrolizumab In Patients With Advanced Hepatocellular
Carcinoma Previously Treated With Sorafenib (Keynote-224): A
Non-Randomised, Open-Label Phase 2 Trial |
Zhu, Andrew X; Finn, Richard S; Edeline, Julien;
Cattan, Stephane; Ogasawara, Sadahisa; Palmer, Daniel; Verslype, Chris;
Zagonel, Vittorina; Fartoux, Laetitia; Vogel, Arndt; Sarker, Debashis;
Verset, Gontran; Chan, Stephen L; Knox, Jennifer; Daniele, Bruno;
Webber, Andrea L; Ebbinghaus, Scot W; Ma, Junshui; Siegel, Abby B;
Cheng, Ann-Lii; Kudo, Masatoshi; Alistar, Angela; Asselah, Jamil; Blanc,
Jean-Frederic; Borbath, Ivan; Cannon, Timothy; Chung, Ki; Cohn, Allen;
Cosgrove, David P; Damjanov, Nevena; Gupta, Mukul; Karino, Yoshivasu;
Karwal, Mark; Kaubisch, Andreas; Kelley, Robin; Van Laethem, Jena-Luc;
Larson, Timothy; Lee, James; Li, Daneng; Manhas, Atisha; Manji, Gulam
Abbas; Numata, Kazushi; Parsons, Benjamin; Paulson, Andrew S.; Pinto,
Carmine; Ramirez, Robert; Ratnam, Suresh; Rizell, Magnus; Rosmorduc,
Olivier; Sada, Yvonne; Sasaki, Yutaka; Stal, Per I; Strasser, Simone;
Trojan, Joerg; Vaccaro, Gina; Van Vlierberghe, Hans; Weiss, Alan; Weiss,
Karl-Heinz; Yamashita, Tatsuya |
The Lancet Oncology |
2018 |
| 10279 |
10.1016/s1470-2045(18)30937-9 |
|
Zhu, Andrew X; Kang, Yoon-Koo; Yen, Chia-Jui; Finn,
Richard S; Galle, Peter R; Llovet, Josep M; Assenat, Eric; Brandi,
Giovanni; Pracht, Marc; Lim, Ho Yeong; Rau, Kun-Ming; Motomura, Kenta;
Ohno, Izumi; Merle, Philippe; Daniele, Bruno; Shin, Dong Bok; Gerken,
Guido; Borg, Christophe; Hiriart, Jean-Baptiste; Okusaka, Takuji;
Morimoto, Manabu; Hsu, Yanzhi; Abada, Paolo B; Kudo, Masatoshi |
The Lancet Oncology |
2019 |
| 10322 |
10.1016/s1470-2045(20)30011-5 |
Camrelizumab In Patients With Previously Treated
Advanced Hepatocellular Carcinoma: A Multicentre, Open-Label,
Parallel-Group, Randomised, Phase 2 Trial |
Qin, Shukui; Ren, Zhenggang; Meng, Zhiqiang; Chen,
Zhendong; Chai, Xiaoli; Xiong, Jianping; Bai, Yuxian; Yang, Lin; Zhu,
Hong; Fang, Weijia; Lin, Xiaoyan; Chen, Xiaoming; Li, Enxiao; Wang,
Linna; Chen, Chunxia; Zou, Jianjun |
The Lancet Oncology |
2020 |
| 10331 |
10.1016/s1470-2045(20)30156-x |
Atezolizumab With Or Without Bevacizumab In
Unresectable Hepatocellular Carcinoma (Go30140): An Open-Label,
Multicentre, Phase 1B Study |
Lee, Michael S; Ryoo, Baek-Yeol; Hsu, Chih-Hung;
Numata, Kazushi; Stein, Stacey; Verret, Wendy; Hack, Stephen P; Spahn,
Jessica; Liu, Bo; Abdullah, Heba; Wang, Yulei; He, Aiwu Ruth; Lee,
Kyung-Hun; Bang, Y-J; Bendell, J; Chao, Y; Chen, J-S; Chung, H C; Davis,
S L; Dev, A; Gane, E; George, B; He, A R; Hochster, H; Hsu, C-H; Ikeda,
M; Lee, J; Lee, M; Mahipal, A; Manji, G; Morimoto, M; Numata, K;
Pishvaian, M; Qin, S; Ryan, D; Ryoo, B-Y; Sasahira, N; Stein, S;
Strickler, J; Tebbutt, N |
The Lancet Oncology |
2020 |
| 13946 |
10.1038/s41572-020-00240-3 |
Hepatocellular Carcinoma |
Llovet, Josep M., 0000-0003-0547-2667; Kelley, Robin
Kate; Villanueva, Augusto, 0000-0003-3585-3727; Singal, Amit G.;
Pikarsky, Eli; Roayaie, Sasan; Lencioni, Riccardo; Koike, Kazuhiko;
Zucman-Rossi, Jessica, 0000-0002-5687-0334; Finn, Richard S. |
Nature Reviews Disease Primers |
2021 |
| 14472 |
10.1038/s41586-021-03362-0 |
Nash Limits Anti-Tumour Surveillance In
Immunotherapy-Treated Hcc |
|
Nature |
2021 |
| 15920 |
10.1053/j.gastro.2019.01.261 |
Biomarkers Associated With Response To Regorafenib In
Patients With Hepatocellular Carcinoma |
Teufel, Michael; Seidel, Henrik; Kochert, Karl;
Meinhardt, Gerold; Finn, Richard S.; Llovet, Josep M.; Bruix, Jordi |
Gastroenterology |
2019 |
| 16047 |
10.1056/nejmoa1717002 |
Cabozantinib In Patients With Advanced And Progressing
Hepatocellular Carcinoma |
Abou-Alfa, Ghassan K.; Meyer, Tim; Cheng, Ann-Lii;
El-Khoueiry, Anthony B.; Rimassa, Lorenza; Ryoo, Baek-Yeol; Cicin,
Irfan; Merle, Philippe; Chen, Yenhsun; Park, Joong-Won; Blanc,
Jean-Frederic; Bolondi, Luigi; Klumpen, Heinz-Josef; Chan, Stephen L.;
Zagonel, Vittorina; Pressiani, Tiziana; Ryu, Min-Hee; Venook, Alan P.;
Hessel, Colin; Borgman-Hagey, Anne E.; Schwab, Gisela; Kelley, Robin
K. |
New England Journal Of Medicine |
2018 |
| 16153 |
10.1056/nejmoa1915745 |
Atezolizumab Plus Bevacizumab In Unresectable
Hepatocellular Carcinoma |
Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi; Galle,
Peter R.; Ducreux, Michel; Kim, Tae-You; Kudo, Masatoshi; Breder,
Valeriy; Merle, Philippe; Kaseb, Ahmed O.; Li, Daneng; Verret, Wendy;
Xu, Derek-Zhen; Hernandez, Sairy; Liu, Juan; Huang, Chen; Mulla, Sohail;
Wang, Yulei; Lim, Ho Yeong; Zhu, Andrew X.; Cheng, Ann-Lii |
New England Journal Of Medicine |
2020 |
| 16991 |
10.1093/annonc/mdz394.029 |
Checkmate 459: A Randomized, Multi-Center Phase Iii
Study Of Nivolumab (Nivo) Vs Sorafenib (Sor) As First-Line (1L)
Treatment In Patients (Pts) With Advanced Hepatocellular Carcinoma
(Ahcc) |
Yau, T.; Park, J.W.; Finn, R.S.; Cheng, A.-L.;
Mathurin, P.; Edeline, J.; Kudo, M.; Han, K.-H.; Harding, J.J.; Merle,
P.; Rosmorduc, O.; Wyrwicz, L.; Schott, E.; Choo, S.P.; Kelley, R.K.;
Begic, D.; Chen, G.; Neely, J.; Anderson, J.; Sangro, B. |
Annals Of Oncology |
2019 |
| 16997 |
10.1093/annonc/mdz446.002 |
Imbrave150: Efficacy And Safety Results From A Ph Iii
Study Evaluating Atezolizumab (Atezo) + Bevacizumab (Bev) Vs Sorafenib
(Sor) As First Treatment (Tx) For Patients (Pts) With Unresectable
Hepatocellular Carcinoma (Hcc) |
Cheng, A.-L.; Qin, S.; Ikeda, M.; Galle, P.; Ducreux,
M.; Zhu, A.; Kim, T.-Y.; Kudo, M.; Breder, V.; Merle, P.; Kaseb, A.; Li,
D.; Verret, W.; Xu, Z.; Hernandez, S.; Liu, J.; Huang, C.; Mulla, S.;
Lim, H.Y.; Finn, R. |
Annals Of Oncology |
2019 |
| 19505 |
10.1158/1078-0432.ccr-18-2484 |
Anti-Pd-1 Antibody Shr-1210 Combined With Apatinib For
Advanced Hepatocellular Carcinoma, Gastric, Or Esophagogastric Junction
Cancer: An Open-Label, Dose Escalation And Expansion Study |
Xu, Jianming; Zhang, Yun; Jia, Ru; Yue, Chunyan; Chang,
Lianpeng; Liu, Rongrui; Zhang, Gairong; Zhao, Chuanhua; Zhang, Yaoyue;
Chen, Chunxia; Wang, Yan; Yi, Xin; Hu, Zhiyuan, 0000-0003-2212-0268;
Zou, Jianjun; Wang, Quanren |
Clinical Cancer Research |
2018 |
| 20262 |
10.1200/jco.19.01307 |
Pembrolizumab As Second-Line Therapy In Patients With
Advanced Hepatocellular Carcinoma In Keynote-240: A Randomized,
Double-Blind, Phase Iii Trial |
Finn, Richard S.; Ryoo, Baek-Yeol; Merle, Philippe;
Kudo, Masatoshi; Bouattour, Mohamed; Lim, Ho Yeong; Breder, Valeriy;
Edeline, Julien; Chao, Yee; Ogasawara, Sadahisa; Yau, Thomas; Garrido,
Marcelo; Chan, Stephen L.; Knox, Jennifer; Daniele, Bruno; Ebbinghaus,
Scot W.; Chen, Erluo; Siegel, Abby B.; Zhu, Andrew X.; Cheng,
Ann-Lii |
Journal Of Clinical Oncology |
2020 |
| 20294 |
10.1200/jco.20.00808 |
Phase Ib Study Of Lenvatinib Plus Pembrolizumab In
Patients With Unresectable Hepatocellular Carcinoma |
Finn, Richard S.; Ikeda, Masafumi; Zhu, Andrew X.;
Sung, Max W.; Baron, Ari D.; Kudo, Masatoshi; Okusaka, Takuji;
Kobayashi, Masahiro; Kumada, Hiromitsu; Kaneko, Shuichi; Pracht, Marc;
Mamontov, Konstantin; Meyer, Tim; Kubota, Tomoki; Dutcus, Corina E.;
Saito, Kenichi; Siegel, Abby B.; Dubrovsky, Leonid; Mody, Kalgi; Llovet,
Josep M. |
Journal Of Clinical Oncology |
2020 |
| 20306 |
10.1200/jco.2017.76.0892 |
Sirvenib: Selective Internal Radiation Therapy Versus
Sorafenib In Asia-Pacific Patients With Hepatocellular Carcinoma |
Chow, Pierce K.H.; Gandhi, Mihir; Tan, Say-Beng; Khin,
Maung Win; Khasbazar, Ariunaa; Ong, Janus; Choo, Su Pin; Cheow, Peng
Chung; Chotipanich, Chanisa; Lim, Kieron; Lesmana, Laurentius A.;
Manuaba, Tjakra W.; Yoong, Boon Koon; Raj, Aloysius; Law, Chiong Soon;
Cua, Ian H.Y.; Lobo, Rolley R.; Teh, Catherine S.C.; Kim, Yun Hwan;
Jong, Yun Won; Han, Ho-Seong; Bae, Si-Hyun; Yoon, Hyun-Ki; Lee,
Rheun-Chuan; Hung, Chien-Fu; Peng, Cheng-Yuan; Liang, Po-Chin; Bartlett,
Adam; Kok, Kenneth Y.Y.; Thng, Choon-Hua; Low, Albert Su-Chong; Goh,
Anthony S.W.; Tay, Kiang Hiong; Lo, Richard H.G.; Goh, Brian K.P.; Ng,
David C.E.; Lekurwale, Ganesh; Liew, Wei Ming; Gebski, Val; Mak, Kenneth
S.W.; Soo, Khee Chee |
Journal Of Clinical Oncology |
2018 |
| 20329 |
10.1200/jco.2019.37.15_suppl.4004 |
Results Of Keynote-240: Phase 3 Study Of Pembrolizumab
(Pembro) Vs Best Supportive Care (Bsc) For Second Line Therapy In
Advanced Hepatocellular Carcinoma (Hcc). |
Finn, Richard S.; Ryoo, Baek-Yeol; Merle, Philippe;
Kudo, Masatoshi; Bouattour, Mohamed; Lim, Ho-Yeong; Breder, Valeriy
Vladimirovich; Edeline, Julien; Chao, Yee; Ogasawara, Sadahisa; Yau,
Thomas; Garrido, Marcelo; Chan, Stephen Lam; Knox, Jennifer J.; Daniele,
Bruno; Ebbinghaus, Scot; Chen, Erluo; Siegel, Abby B.; Zhu, Andrew X.;
Cheng, Ann-Lii |
Journal Of Clinical Oncology |
2019 |
| 20330 |
10.1200/jco.2019.37.15_suppl.4012 |
Nivolumab (Nivo) + Ipilimumab (Ipi) Combination Therapy
In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc): Results
From Checkmate 040. |
Yau, Thomas; Kang, Yoon-Koo; Kim, Tae-You; El-Khoueiry,
Anthony B.; Santoro, Armando; Sangro, Bruno; Melero, Ignacio; Kudo,
Masatoshi; Hou, Ming-Mo; Matilla, Ana; Tovoli, Francesco; Knox, Jennifer
J.; He, Aiwu Ruth; El-Rayes, Bassel F.; Acosta-Rivera, Mirelis; Neely,
Jaclyn; Shen, Yun; Baccan, Carlos; Dela Cruz, Christine Marie; Hsu,
Chiun |
Journal Of Clinical Oncology |
2019 |
| 20338 |
10.1200/jco.2019.37.4_suppl.327 |
Checkmate-040: Nivolumab (Nivo) In Patients (Pts) With
Advanced Hepatocellular Carcinoma (Ahcc) And Child-Pugh B (Cpb)
Status. |
Kudo, Masatoshi; Matilla, Ana; Santoro, Armando;
Melero, Ignacio; Gracian, Antonio Cubillo; Acosta-Rivera, Mirelis; Choo,
Su Pin; El-Khoueiry, Anthony B.; Kuromatsu, Ryoko; El-Rayes, Bassel F.;
Numata, Kazushi; Itoh, Yoshito; Di Costanzo, Francesco; Crysler, Oxana
V.; Reig, Maria; Shen, Yun; Neely, Jaclyn; Dela Cruz, Christine Marie;
Baccan, Carlos; Sangro, Bruno |
Journal Of Clinical Oncology |
2019 |
| 20346 |
10.1200/jco.2020.38.15_suppl.4508 |
Efficacy, Tolerability, And Biologic Activity Of A
Novel Regimen Of Tremelimumab (T) In Combination With Durvalumab (D) For
Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc). |
Kelley, Robin Kate; Sangro, Bruno; Harris, William
Proctor; Ikeda, Masafumi; Okusaka, Takuji; Kang, Yoon-Koo; Qin, Shukui;
Tai, Wai Meng David; Lim, Ho Yeong; Yau, Thomas; Yong, Wei-Peng; Cheng,
Ann-Lii; Gasbarrini, Antonio; De Braud, Filippo G.; Bruix, Jordi; Borad,
Mitesh J.; He, Philip; Negro, Alejandra; Kudo, Masatoshi; Abou-Alfa,
Ghassan K. |
Journal Of Clinical Oncology |
2020 |
| 20350 |
10.1200/jco.2020.38.4_suppl.478 |
Nivolumab (Nivo) + Ipilimumab (Ipi) + Cabozantinib
(Cabo) Combination Therapy In Patients (Pts) With Advanced
Hepatocellular Carcinoma (Ahcc): Results From Checkmate 040. |
Yau, Thomas; Zagonel, Vittorina; Santoro, Armando;
Acosta-Rivera, Mirelis; Choo, Su Pin; Matilla, Ana; He, Aiwu Ruth;
Cubillo Gracian, Antonio; El-Khoueiry, Anthony B.; Sangro, Bruno;
Eldawy, Tarek; Bruix, Jordi; Frassineti, Giovanni; Vaccaro, Gina M.;
Tschaika, Marina; Scheffold, Christian; Shen, Yun; Neely, Jaclyn;
Piscaglia, Fabio |
Journal Of Clinical Oncology |
2020 |
| 20351 |
10.1200/jco.2021.39.3_suppl.267 |
Imbrave150: Updated Overall Survival (Os) Data From A
Global, Randomized, Open-Label Phase Iii Study Of Atezolizumab (Atezo) +
Bevacizumab (Bev) Versus Sorafenib (Sor) In Patients (Pts) With
Unresectable Hepatocellular Carcinoma (Hcc). |
Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi; Galle,
Peter R.; Ducreux, Michel; Kim, Tae-You; Lim, Ho Yeong; Kudo, Masatoshi;
Breder, Valeriy Vladimirovich; Merle, Philippe; Kaseb, Ahmed Omar; Li,
Daneng; Verret, Wendy; Shao, Hui; Liu, Juan; Li, Lindong; Zhu, Andrew
X.; Cheng, Ann-Lii |
Journal Of Clinical Oncology |
2021 |